Managing chronic neuropathic pain with medical cannabis is challenging, especially when accurate dosing is required for safe and effective treatment. Research Podcast #3 presents the findings of Syqe’s 2020 clinical study, which evaluated the safety and effectiveness of the SyqeAir Inhaler for delivering metered, low-dose cannabis treatment to patients with chronic neuropathic pain. Conducted in a real-world hospital setting, this study demonstrates how the SyqeAir Inhaler can provide reliable pain relief while minimizing adverse events.
Read the full article here and listen to this short podcast on the study (16 minutes):
